Skip to content
Delayed ~15 min

TRAX FIRST TRACKS BIOTHERAPEUTICS INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 14 analyst firms say about FIRST TRACKS BIOTHERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

47.90 USD+2.47 (+5.44%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+43.2%to the avg target 68.60 USD+20.70 USD
Buy 12 · Hold 1 · Sell 0

13 rated views · 14 analyst/firm records · 14 firms

Latest report16 Oct 2026avg report date 23 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8076
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8071

Recent analyst activity · last 90 days

Our tracked history has 20 reports on TRAX from 12 analyst firms in the last 90 days (14 firms in the past year).

Comparing each firm's latest target with its previous one: 4 raised their price target, 3 left it unchanged and 4 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Leerink Partners raised its target from $46.00 (set 24 Apr 2026) to $90.00 on 16 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BarclaysEtzer DaroutBuy13 Aug 202665.00 USD
Canaccord GenuityEdward NashBuy13 Oct 202660.00 USD
Evercore ISIGavin Clark-GartnerBuy18 Sep 2026Conflicting reports · excluded
GuggenheimYastin SunejaBuy16 Sep 2026Conflicting reports · excluded
H.C. WainwrightEmily BodnarBuy3 Sep 202657.00 USD
JPMorganAnupam RamaBuy23 Apr 202631.00 USD
Leerink PartnersDavid RisingerBuy16 Oct 202690.00 USD
Piper SandlerYasmeen RahimiBuy13 Aug 202695.00 USD
UBSMichael YeeBuy16 Sep 202665.00 USD · 10 Aug 2026
WedbushMartin FanBuy13 Aug 202670.00 USD
Weiss RatingsUnnamed analyst—8 Oct 2026—
Wells FargoDerek ArchilaBuy12 Oct 202670.00 USD
Wolfe ResearchAndy G ChenBuy18 Aug 202683.00 USD
Data feed RESEARCHResearch TeamHold27 Apr 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 03:03 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.